104 related articles for article (PubMed ID: 10831033)
21. Are the atypical antipsychotic drugs antidepressants?
Parker G; Malhi G
J Clin Psychopharmacol; 2002 Feb; 22(1):94-5. PubMed ID: 11799351
[No Abstract] [Full Text] [Related]
22. Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases.
Agarwal V; Kumar P
J Clin Psychiatry; 2001 Apr; 62(4):298-9. PubMed ID: 11379849
[No Abstract] [Full Text] [Related]
23. Thrombocytopenia possibly associated with olanzapine and subsequently with benztropine mesylate.
Bogunovic O; Viswanathan R
Psychosomatics; 2000; 41(3):277-8. PubMed ID: 10849461
[No Abstract] [Full Text] [Related]
24. Olanzapine use in women with antipsychotic-induced hyperprolactinemia.
Canuso CM; Hanau M; Jhamb KK; Green AI
Am J Psychiatry; 1998 Oct; 155(10):1458. PubMed ID: 9766782
[No Abstract] [Full Text] [Related]
25. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
Kelly DL; Kreyenbuhl J; Love RC; Van-Duong Q; Conley RR
J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
[No Abstract] [Full Text] [Related]
26. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
[TBL] [Abstract][Full Text] [Related]
27. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
[TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of antipsychotic drugs.
Meibach RC
Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
[No Abstract] [Full Text] [Related]
29. Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
Gheuens J; Grebb JA
J Clin Psychopharmacol; 1998 Apr; 18(2):176-9. PubMed ID: 9555606
[No Abstract] [Full Text] [Related]
30. Comments on article by Tran and colleagues, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
Schooler NR
J Clin Psychopharmacol; 1998 Apr; 18(2):174-6. PubMed ID: 9555605
[No Abstract] [Full Text] [Related]
31. Clinical trial response and dropout rates with olanzapine versus risperidone.
Santarlasci B; Messori A
Ann Pharmacother; 2003 Apr; 37(4):556-63. PubMed ID: 12659615
[TBL] [Abstract][Full Text] [Related]
32. Priapism associated with polypharmacy.
Seger A; Lamberti JS
J Clin Psychiatry; 2001 Feb; 62(2):128. PubMed ID: 11247100
[No Abstract] [Full Text] [Related]
33. Economic evaluations of olanzapine and risperidone.
Shaw JW
Am J Health Syst Pharm; 2002 Jul; 59(14):1366-75. PubMed ID: 12132564
[No Abstract] [Full Text] [Related]
34. Anticholinergics in dementia and other confounding problems.
Friedman JH
Am J Geriatr Psychiatry; 2006 Apr; 14(4):384; author reply 384-5. PubMed ID: 16582052
[No Abstract] [Full Text] [Related]
35. Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient.
Meyer JM; Marsh J; Simpson G
Biol Psychiatry; 1998 Oct; 44(8):791-4. PubMed ID: 9798086
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine to treat the acute mania of bipolar disorder.
Price PL
S D J Med; 2000 Dec; 53(12):523. PubMed ID: 11132516
[No Abstract] [Full Text] [Related]
37. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
38. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
39. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study.
Lavalaye J; Booij J; Linszen DH; Reneman L; van Royen EA
Psychopharmacology (Berl); 2001 Jun; 156(1):53-7. PubMed ID: 11465633
[TBL] [Abstract][Full Text] [Related]
40. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
Meyer JM
J Clin Psychiatry; 2002 May; 63(5):425-33. PubMed ID: 12019668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
